REGENXBIO Inc. Files 8-K on Shareholder Matters

Ticker: RGNX · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1590877

Sentiment: neutral

Topics: corporate-governance, shareholder-matters, filing

TL;DR

REGENXBIO filed an 8-K on shareholder votes, check their governance.

AI Summary

REGENXBIO Inc. filed an 8-K on June 3, 2025, reporting on matters submitted to a vote of security holders as of May 30, 2025. The filing details the company's corporate structure and its principal executive offices located at 9804 Medical Center Drive, Rockville, Maryland.

Why It Matters

This filing provides transparency regarding corporate governance and shareholder voting activities for REGENXBIO Inc., which is crucial for investors to understand the company's decision-making processes.

Risk Assessment

Risk Level: low — This is a routine corporate filing detailing shareholder matters and company information, not indicating any immediate financial or operational risks.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted to a vote of REGENXBIO Inc. security holders?

The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 30, 2025.

What is the principal executive office address for REGENXBIO Inc.?

The principal executive offices of REGENXBIO Inc. are located at 9804 Medical Center Drive, Rockville, Maryland 20850.

What is the SEC file number for REGENXBIO Inc.?

The SEC file number for REGENXBIO Inc. is 001-37553.

What is the IRS Employer Identification Number for REGENXBIO Inc.?

The IRS Employer Identification Number for REGENXBIO Inc. is 47-1851754.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding REGENXBIO Inc. (RGNX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing